RICE, Z.; GOODERHAM, M.; LEBWOHL, M. G.; SIMPSON, E. L. .; BOGUNIEWICZ, M.; WOLLENBERG, A.; LAZARICIU, I.; CHAN, G. L.; ALDERFER, J.; WATKINS, M. Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s154, 2023. DOI: 10.25251/skin.7.supp.154. Disponível em: https://jofskin.org/index.php/skin/article/view/1980. Acesso em: 3 jul. 2024.